[Assessment of feasibility of formulation of a preparation for growth inhibition of metronidazole-resistant strains isolated from periodontal pockets]
- PMID: 16047859
- DOI: 10.2298/vsp0506453t
[Assessment of feasibility of formulation of a preparation for growth inhibition of metronidazole-resistant strains isolated from periodontal pockets]
Abstract
Introduction: Topical metronidazole benzoate preparations, applied directly into the space between the teeth and, periodontal tissue, are the treatment of choice for periodontal pockets. Oleogels and hydrogels, as the biomucoadhesive bases for the manufacturing of these preparations, were developed in our previous trials. The aim of our latest research was to develop a preparation that would solve the problem of inhibiting the metronidazole-resistant anaerobic strains, isolated from the periodontal pockets.
Methods: Metronidazole-resistant strains were isolated from the periodontal pocket swabs, using the established susceptibility testing. Further testing of the antimicrobial activity of the prepared formulations was performed by the membrane-free diffusion method in agar gel. Oleogels and hydrogels were tested with: tetracycline (2.5%), metronidazole (25%), and metronidazole benzoate (40%), as well as with oleogels and hydrogels containing the combination of 2.5% tetracycline and 40% metronidazole benzoate.
Results: Satisfying results were achieved with the preparation containing 2.5% tetracycline along with metronidazole benzoate. The main fact revealed by this study was that there was no synergism in tetracycline and metronidazole benzoate activities, if the strain was susceptible to both active substances.
Conclusion: The best results in the inhibition of the growth of metronidazole-resistant anaerobic strains were obtained by 2.5% tetracycline and metronidazole benzoate preparations in oleogel base.
Similar articles
-
Effects of topical application of metronidazole-containing mucoadhesive lipogel in periodontal pockets.Vojnosanit Pregl. 2005 Jul-Aug;62(7-8):565-8. doi: 10.2298/vsp0508565t. Vojnosanit Pregl. 2005. PMID: 16171020 Clinical Trial.
-
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.J Periodontol. 1999 Aug;70(8):888-92. doi: 10.1902/jop.1999.70.8.888. J Periodontol. 1999. PMID: 10476896
-
Occurrence of porphyromonas gingivalis and its antibacterial susceptibility to metronidazole and tetracycline in patients with chronic periodontitis.Acta Odontol Latinoam. 2014;27(3):137-44. doi: 10.1590/S1852-48342014000300007. Acta Odontol Latinoam. 2014. PMID: 25560693
-
Pharmacological control of periodontal disease. II. Antimicrobial agents.J Dent. 1995 Feb;23(1):5-14. doi: 10.1016/0300-5712(95)90654-z. J Dent. 1995. PMID: 7876417 Review.
-
The local drug delivery of tetracycline, metronidazole, and chlorhexidine in periodontal therapy.J Dent Hyg. 1992 Nov-Dec;66(9):410-6. J Dent Hyg. 1992. PMID: 1298810 Review. No abstract available.
Cited by
-
Oleogel-based drug delivery for the treatment of periodontitis: current strategies and future perspectives.F1000Res. 2023 Sep 27;12:1228. doi: 10.12688/f1000research.140173.1. eCollection 2023. F1000Res. 2023. PMID: 38690138 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical